Literature DB >> 25154049

Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).

Marco Daperno1, Michele Comberlato2, Fabrizio Bossa3, Livia Biancone4, Andrea G Bonanomi5, Andrea Cassinotti6, Rocco Cosintino7, Giovanni Lombardi8, Roberto Mangiarotti7, Alfredo Papa9, Roberta Pica10, Fernando Rizzello11, Renata D'Incà12, Ambrogio Orlando13.   

Abstract

BACKGROUND: Endoscopic activity has become a therapeutic endpoint in inflammatory bowel disease. Aim of this study was to evaluate inter-observer agreement for endoscopic scores in a real-life setting.
METHODS: 14 gastroenterologists with experience in inflammatory bowel disease care and endoscopic scoring reviewed videos of ulcerative colitis (n=13) and postoperative (n=10) and luminal (n=8) Crohn's disease. The Mayo subscore for ulcerative colitis, Rutgeerts score for postoperative Crohn's disease, Crohn's disease endoscopic index of severity (CDEIS), and the simple endoscopic score-Crohn's disease (SES-CD) for luminal Crohn's disease were calculated. A subset of five endoscopic clips were assessed by 30 general gastroenterologists without specific experience in endoscopic scores. Kappa statistics and intraclass correlation coefficients were used to measure agreement.
RESULTS: Mayo subscore agreement was suboptimal: kappas were 0.53 (95% confidence interval 0.47-0.56) and 0.71 (0.67-0.76) for the two groups. Rutgeerts score agreement was fair: kappas were 0.57 (0.51-0.65) and 0.67 (0.60-0.72). Agreements for CDEIS and SES-CD were good: intraclass correlation coefficients for the two groups were 0.83 (0.54-1.00) and 0.67 (0.36-0.97) for CDEIS and 0.93 (0.76-1.00) and 0.68 (0.35-0.97) for SES-CD, respectively.
CONCLUSION: The reproducibility of endoscopic scores in inflammatory bowel disease remains suboptimal, which could potentially have major effects on therapeutic choices.
Copyright © 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CDEIS; Endoscopic scores; Interobserver agreement; Mayo endoscopic subscore; Rutgeerts’ score; SES-CD

Mesh:

Substances:

Year:  2014        PMID: 25154049     DOI: 10.1016/j.dld.2014.07.010

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  17 in total

1.  The new simplified MARIA score applies beyond clinical trials: A suitable clinical practice tool for Crohn's disease that parallels a simple endoscopic index and fecal calprotectin.

Authors:  Joana Roseira; Ana Rita Ventosa; Helena Tavares de Sousa; Jorge Brito
Journal:  United European Gastroenterol J       Date:  2020-07-14       Impact factor: 4.623

Review 2.  Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?

Authors:  Robert Battat; Parambir S Dulai; Christopher Ma; Vipul Jairath; Brian G Feagan; William J Sandborn; Reena Khanna
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-04

3.  Endoscopy and cross-sectional imaging for assessing Crohn׳s disease activity.

Authors:  Ryan W Stidham; Raymond K Cross
Journal:  Tech Gastrointest Endosc       Date:  2016-07

Review 4.  Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases.

Authors:  Aamir Javaid; Omer Shahab; William Adorno; Philip Fernandes; Eve May; Sana Syed
Journal:  Inflamm Bowel Dis       Date:  2022-06-03       Impact factor: 7.290

Review 5.  Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.

Authors:  Reena Khanna; Sigrid A Nelson; Brian G Feagan; Geert D'Haens; William J Sandborn; G Y Zou; John K MacDonald; Claire E Parker; Vipul Jairath; Barrett G Levesque
Journal:  Cochrane Database Syst Rev       Date:  2016-08-08

Review 6.  Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis.

Authors:  Paulina Núñez F; Noa Krugliak Cleveland; Rodrigo Quera; David T Rubin
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

7.  A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative Colitis.

Authors:  Floris De Voogd; Rune Wilkens; Krisztina Gecse; Mariangela Allocca; Kerri Novak; Cathy Lu; Geert D'Haens; Christian Maaser
Journal:  J Crohns Colitis       Date:  2021-08-02       Impact factor: 9.071

Review 8.  Implementation of the simple endoscopic activity score in crohn's disease.

Authors:  Efstratios Koutroumpakis; Konstantinos H Katsanos
Journal:  Saudi J Gastroenterol       Date:  2016 May-Jun       Impact factor: 2.485

9.  The 2 + 1 paradigm: an efficient algorithm for central reading of Mayo endoscopic subscores in global multicenter phase 3 ulcerative colitis clinical trials.

Authors:  Harris A Ahmad; Klaus Gottlieb; Fez Hussain
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-09-11

Review 10.  Endoscopic Disease Activity in Inflammatory Bowel Disease.

Authors:  Shara Nguyen Ket; Rebecca Palmer; Simon Travis
Journal:  Curr Gastroenterol Rep       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.